Abstract
Failed Fontan Patients with high cardiac output (CO) heart failure (HF) might have vasodilatory syndrome and markedly high mortality rates. The aim of this study was to review the clinical effects of vasoconstrictor therapy (VCT) for failed Fontan hemodynamics. We retrospectively reviewed 10 consecutive patients with Fontan failure (median age, 33 years) and high CO–HF who had received VCT. The hemodynamics were characterized by high central venous pressure (CVP: median, 16 mm Hg), low systolic blood pressure (median, 83 mm Hg), low systemic vascular resistance (median, 8.8 U·m2), high cardiac index (median, 4.6 L/min/m2), and low arterial oxygen saturation (median, 89%). VCT included intravenous noradrenaline infusion for five unstable patients, oral midodrine administration for nine stable patients, and both for four patients. After VCT introduction with a median interval of 1.7 months, the median systolic blood pressure (102 mm Hg, p = 0.004), arterial oxygen saturation (90%, p = 0.03), and systemic vascular resistance (12.1 U·m2, p = 0.13) increased without significant changes in CVP or cardiac index. After a median follow-up of 21 months, the number of readmissions per year decreased from 4 (1–11) to 1 (0–9) (p = 0.25), and there were no VCT-related complications; however, five patients (50%) developed hepatic encephalopathy, and six patients (60%) eventually died. VCT was safely introduced and could prevent the rapidly deteriorating Fontan hemodynamics. VCT could be an effective therapeutic strategy for failed Fontan patients with high CO–HF.
Similar content being viewed by others
References
d’Udekem Y, Iyengar AJ, Cochrane AD et al (2007) The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation 116:157-I164
Ohuchi H, Kagisaki K, Miyazaki A et al (2011) Impact of the evolution of the Fontan operation on early and late mortality: a single-center experience of 405 patients over 3 decades. Ann Thorac Surg 92:1457–1466
Khairy P, Fernandes SM, Mayer JE Jr et al (2008) Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117:85–92
Diller GP, Kempny A, Alonso-Gonzalez R et al (2015) Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation 132:2118–2125
Assenza GE, Graham DA, Landzberg MJ et al (2013) MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart 99:491–496
Pundi K, Pundi KN, Kamath PS et al (2016) Liver disease in patients after the Fontan operation. Am J Cardiol 117:456–460
Iwakiri Y, Groszmann RJ (2006) The hyperdynamic circulation of chronic liver disease: from the patient to the molecule. Hepatology 43(Suppl 1):S121–S131
Eelco FM (2016) Wijdicks. Hepatic encephalopathy New Engl J Med 375:1660–1670
Ohuchi H (2017) Where is the “optimal” Fontan hemodynamics? Korean Circ J 47:842–857
Ohuchi H (2016) Adult patients with Fontan circulation: what we know and how to manage adults with Fontan circulation? J Cardiol 68:181–189
Agnoletti G, Gala S, Ferroni F et al (2017) Endothelin inhibitors lower pulmonary vascular resistance and improve functional capacity in patients with Fontan circulation. J Thorac Cardiovasc Surg 153:1468–1475
Ohuchi H, Miyazaki A, Negishi J et al (2017) Hemodynamic determinants of mortality after Fontan operation. Am Heart J 189:9–18
Mori M, Aguirre AJ, Elder RW et al (2014) Beyond a broken heart: circulatory dysfunction in the failing Fontan. Pediatr Cardiol 35:569–579
Hebson CL, McCabe NM, Elder RW et al (2013) Hemodynamic phenotype of the failing Fontan in an adult population. Am J Cardiol 112:1943–1947
Waypa GB, Schumacker PT (2010) Hypoxia-induced changes in pulmonary and systemic vascular resistance: where is the O2 sensor? Respir Physiol Neurobiol 174:201–211
Groszmann RJ (1994) Hyperdynamic circulation of liver disease 40 years later pathophysiology and clinical consequences. Hepatology 20:13591363
SchrierRW AV, Bernardi M et al (1988) Peripheral arterial vasodilatation hypothesis a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151–1157
de Mattos ÁZ, de Mattos AA, Méndez-Sánchez N (2016) Hepatorenal syndrome: current concepts related to diagnosis and management. Ann Hepatol 15:474–481
Cohn JN (1976) Renal hemodynamic alterations in liver disease. Perspect Nephrol Hypertens 3:234–255
Ferenci P, Lockwood A, Mullen K et al (2002) Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716–721
Romero-GomezM BF, Garcia-Valdecasas MS et al (2001) Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 96:2718–2723
Wong RJ, Gish RG, Ahmed A (2014) Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation. Liver Transpl 20:1454–1461
Funding
The authors have no financial relationships relevant to this article to disclose.
Author information
Authors and Affiliations
Contributions
HM Investigation, Data Curation, Writing—Original Draft, Visualization. Hideo Ohuchi: Conceptualization, Methodology, Writing, Review & Editing, Project administration. YH Resources. TI Resources. HS Resources. KK Resources. MN Statistic analysis, Supervision.
Corresponding author
Ethics declarations
Conflict of interest
All the authors declared that they have no conflict of interest.
Ethical Approval
The Ethics Committee of the National Cardiovascular Center approved the study protocol (M23-002–4), and consent was waived due to the retrospective nature of the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Miike, H., Ohuchi, H., Hayama, Y. et al. Systemic Artery Vasoconstrictor Therapy in Fontan Patients with High Cardiac Output-Heart Failure: A Single-Center Experience. Pediatr Cardiol 42, 700–706 (2021). https://doi.org/10.1007/s00246-020-02532-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-020-02532-7